Expanded Access Program Using Uromune for Patients With Recurrent Urinary Tract Infections (rUTI)
Sponsored by Impatients N.V. trading as myTomorrows
About this trial
Last updated 2 years ago
Study ID
2019-UROMUNEINM-EU
Status
No longer available
Type
Expanded Access
Placebo
No
Accepting
All
All
What is this trial about?
An Expanded Access Program for UROMUNE® for patients suffering from recurrent/chronic urinary
tract infections of diverse etiology. This is for individuals for whom antibiotic therapy has
failed, but of consideration in all cases, taking into account antibiotic-induced adverse
reactions and increasing antibiotic resistance.
What are the participation requirements?
Inclusion Criteria
- Patients suffering recurrent urinary tract infections of diverse etiology.
Exclusion Criteria
- Individuals being allergic to any of the ingredients of UROMUNE®.
- Pregnancy and breast feeding. There are neither specific studies nor a formal contraindication, the physician should value benefits/risk.